arginine and Brain Hemorrhage, Cerebral

arginine has been researched along with Brain Hemorrhage, Cerebral in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.70)18.2507
2000's13 (48.15)29.6817
2010's12 (44.44)24.3611
2020's1 (3.70)2.80

Authors

AuthorsStudies
Appel, D; Böger, R; Czorlich, P; Haddad, M; Hannemann, J; Lamszus, K; Mader, MM; Mohme, M; Schwedhelm, E; Westphal, M1
Barreto, AD; Cai, C; Ford, GA; Grotta, JC; Pedroza, C; Rahbar, MH; Shen, L; Tyson, J1
Bode-Böger, SM; Dirks, M; Kielstein, JT; Lanfermann, H; Li, N; Lichtinghagen, R; Martens-Lobenhoffer, J; Raab, P; Schuppner, R; Weissenborn, K; Worthmann, H1
Barreto, AD; Berekashvili, K; Blackburn, S; Chen, PR; Dannenbaum, M; Grotta, JC; Misra, V; Shen, L; Soomro, J1
Buchan, AM; Sutherland, BA1
Chen, JL; Chen, W; Fan, RM; Han, C; Jiao, S; Li, G; Wang, CM; Xia, XP; Yao, ST; Zeng, YC1
Agulla, J; Almeida, Á; Bobo-Jiménez, V; Bolaños, JP; Castillo, J; Duarte, JJ; Gómez-Sánchez, JC; Ramos-Araque, ME; Rodríguez, C; Sobrino, T1
de Vries, LS; Groenendaal, F; Koopman, C; Mancini, G; van der Worp, HB; Van Schooneveld, M; Verbeek, E; Verheijen, FW; Witkamp, TD1
Connolly, ES; Garrett, MC; Komotar, RJ; Lambris, JD; Magotti, P; Otten, ML; Rynkowski, MA; Starke, RM1
Daneshtalab, N; Smeda, JS1
Ballarin, R; Bertolotti, M; Cautero, N; De Blasiis, MG; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guerrini, GP; Iemmolo, RM; Marino, M; Montalti, R; Rompianesi, G; Smerieri, N; Spaggiari, M; Zivieri, S1
Chen, S; Deb, M; Li, N; Weissenborn, K; Worthmann, H1
Qu, F; Zhang, CD; Zhou, ZH1
Alexandrov, AV; Balucani, C; Barlinn, K; Barreto, AD; Chen, Z; Demchuk, AM; Garami, Z; Gonzales, NR; Grotta, JC; Lee, J; Lyden, P; Martin-Schild, S; Mikulik, R; Pandurengan, R; Rahbar, MH; Savitz, SI; Shen, L; Sisson, A; Sugg, RM; Tsivgoulis, G; Wu, TC1
Alexandrov, AV; Bavarsad Shahripour, R1
Hoff, JT; Hua, Y; Keep, RF; Kitaoka, T; Xi, G1
Hoff, JT; Hua, Y; Keep, RF; Kitaoka, T; Nagao, S; Xi, G1
Fujisawa, H; Koizumi, H; Nagatsuna, T; Nomura, S; Suehiro, E; Suzuki, M1
Buravkov, SV; Fadiukova, OE; Koshelev, VB; Krushinskiĭ, AL; Kuzenkov, VS; Reutov, VP1
Brattström, L; Brudin, L; Carlsson, M; Nilsson, I; Palmqvist, P; Teerlink, T; Wanby, P1
Akaike, A; Fujimoto, S; Katsuki, H; Kume, T1
Alexandrov, AV; Baraniuk, S; Garami, Z; Gonzales, NR; Grotta, JC; Matherne, DE; Mikulik, R; Moyé, LA; Pary, JK; Shaltoni, HM; Shaw, SG; Sugg, RM; Uchino, K1
Akaike, A; Fujimoto, S; Katsuki, H; Kume, T; Ohnishi, M; Takagi, M1
Avila, MA; DeWitt, DS; Grady, JJ; Prough, DS; Sell, SL; Vergara, L; Yu, G1
Fukuuchi, Y; Gomi, S; Mihara, B; Nagata, E; Nogawa, S; Nozaki, H; Shirai, T; Tanaka, K1
Berens, KL; Brown, PM; Chopp, M; Lu, M; Morris, DC; Zhang, L; Zhang, ZG1
Hamada, R; Matsuoka, H1

Reviews

3 review(s) available for arginine and Brain Hemorrhage, Cerebral

ArticleYear
Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage.
    Neurological research, 2011, Volume: 33, Issue:5

    Topics: Animals; Arginine; Cerebral Hemorrhage; Humans; Nitric Oxide; Nitric Oxide Synthase

2011
Ancillary approaches to plasminogen activators.
    Annals of the New York Academy of Sciences, 2012, Volume: 1268

    Topics: Anticoagulants; Arginine; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Collateral Circulation; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hypothermia, Induced; Low-Level Light Therapy; Pipecolic Acids; Plasminogen Activators; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Sulfonamides; Thrombolytic Therapy; Tirofiban; Tyrosine; Ultrasonic Therapy; Vasodilator Agents

2012
Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?
    CNS drugs, 2002, Volume: 16, Issue:8

    Topics: Antithrombins; Arginine; Brain; Brain Edema; Cerebral Hemorrhage; Humans; Neurons; Pilot Projects; Pipecolic Acids; Sulfonamides; Survival Rate; Thrombin; Treatment Outcome

2002

Trials

2 trial(s) available for arginine and Brain Hemorrhage, Cerebral

ArticleYear
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
    Stroke, 2017, Volume: 48, Issue:6

    Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pipecolic Acids; Severity of Illness Index; Stroke; Sulfonamides; Tissue Plasminogen Activator

2017
Argatroban tPA stroke study: study design and results in the first treated cohort.
    Archives of neurology, 2006, Volume: 63, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Cerebral Hemorrhage; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Recombinant Proteins; Research Design; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome

2006

Other Studies

22 other study(ies) available for arginine and Brain Hemorrhage, Cerebral

ArticleYear
Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2021, Volume: 41, Issue:8

    Topics: Aged; Arginine; Case-Control Studies; Cerebral Hemorrhage; Chromatography, High Pressure Liquid; Citrulline; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Risk Factors; Tandem Mass Spectrometry; Up-Regulation

2021
Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema.
    Journal of neuroinflammation, 2017, Dec-13, Volume: 14, Issue:1

    Topics: Aged; Aged, 80 and over; Arginine; Brain Edema; Cerebral Hemorrhage; Female; Hematoma; Humans; Male

2017
Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:12

    Topics: Aged; Aged, 80 and over; Arginine; Cerebral Hemorrhage; Combined Modality Therapy; Drug Therapy, Combination; Endovascular Procedures; Feasibility Studies; Fibrinolytic Agents; Humans; Incidence; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Postoperative Complications; Stroke; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

2018
Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:11

    Topics: Animals; Arginine; Brain; Cerebral Hemorrhage; Cerebrovascular Circulation; Disease Models, Animal; Drug Carriers; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Wistar; Survival Analysis; Tissue Plasminogen Activator

2013
Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.
    Clinical and experimental immunology, 2014, Volume: 175, Issue:2

    Topics: Animals; Apoptosis; Arginine; Brain Edema; Cerebral Hemorrhage; Complement C5a; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Peptides, Cyclic; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptor, Anaphylatoxin C5a; RNA, Messenger; Stroke; Sulfonamides; Tubulin

2014
Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism.
    Cell death and differentiation, 2017, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Animals; Apoptosis; Arginine; Bone Marrow Cells; Brain; Cells, Cultured; Cerebral Hemorrhage; Chemokine CXCL12; Collagenases; Disease Models, Animal; Endothelial Progenitor Cells; Female; Humans; Male; Mice; Mice, Transgenic; Middle Aged; Neovascularization, Physiologic; Polymorphism, Single Nucleotide; Proline; Tomography, X-Ray Computed; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2017
COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage.
    Annals of neurology, 2009, Volume: 65, Issue:1

    Topics: Arginine; Cerebral Hemorrhage; Collagen Type IV; DNA Mutational Analysis; Female; Glycine; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Premature Birth; Siblings

2009
Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.
    Brain research, 2009, Nov-17, Volume: 1298

    Topics: Analysis of Variance; Animals; Arginine; Behavior, Animal; Benzhydryl Compounds; Body Water; Brain; Brain Chemistry; Cerebral Hemorrhage; Cytoprotection; Drug Synergism; Exploratory Behavior; Flow Cytometry; Granulocytes; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Peptides, Cyclic; Random Allocation; Receptor, Anaphylatoxin C5a; Receptors, Complement; Spatial Behavior; Time Factors

2009
Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke.
    Cardiovascular research, 2010, Apr-01, Volume: 86, Issue:1

    Topics: Animals; Arginine; Biopterins; Blood Pressure; Cerebral Hemorrhage; Cerebrovascular Circulation; Enzyme Inhibitors; Homeostasis; Hypertension; Male; Middle Cerebral Artery; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Vasodilation

2010
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report.
    Transplantation proceedings, 2010, Volume: 42, Issue:4

    Topics: Amino Acid Substitution; Apolipoprotein E2; Arginine; Cerebral Hemorrhage; Cysteine; Female; Heterozygote; Homozygote; Humans; Liver Transplantation; Middle Aged; Mutation; Tissue Donors

2010
Systemic administration of argatroban inhibits protease-activated receptor-1 expression in perihematomal tissue in rats with intracerebral hemorrhage.
    Brain research bulletin, 2011, Oct-10, Volume: 86, Issue:3-4

    Topics: Animals; Arginine; Blotting, Western; Body Water; Brain Chemistry; Brain Edema; Cerebral Hemorrhage; Female; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, PAR-1; Stereotaxic Techniques; Sulfonamides

2011
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Stroke, 2012, Volume: 43, Issue:3

    Topics: Aged; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Cerebral Veins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Pipecolic Acids; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Transcranial

2012
Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage.
    Stroke, 2002, Volume: 33, Issue:12

    Topics: Animals; Antithrombins; Arginine; Brain; Brain Chemistry; Brain Edema; Cerebral Hemorrhage; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hemoglobins; Infusions, Parenteral; Male; Microinjections; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Sulfonamides; Time Factors; Treatment Outcome; Water

2002
Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat.
    Acta neurochirurgica. Supplement, 2003, Volume: 86

    Topics: Animals; Antithrombins; Arginine; Brain; Brain Edema; Cerebral Hemorrhage; Collagenases; Drug Administration Schedule; Hematoma; Injections; Injections, Intraperitoneal; Male; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides

2003
Systemic administration of argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: histopathological assessment.
    Cerebrovascular diseases (Basel, Switzerland), 2005, Volume: 19, Issue:3

    Topics: Animals; Anticoagulants; Arginine; Astrocytes; Brain Edema; Cerebral Hemorrhage; Hematoma; Male; Neutrophils; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides

2005
[Antistress and angioprotective influence of nitric oxide in epilepsy-prone rats of Krushinskiĭ-Molodkina strain].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2005, Volume: 91, Issue:1

    Topics: Acoustic Stimulation; Adaptation, Physiological; Animals; Arginine; Brain; Cerebral Hemorrhage; Cerebrovascular Circulation; Epilepsy, Reflex; Hypoxia; Male; Middle Cerebral Artery; NADPH Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase; Rats

2005
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
    Atherosclerosis, 2006, Volume: 185, Issue:2

    Topics: Acute Disease; Aged; Arginine; Biomarkers; Cerebral Hemorrhage; Cerebral Infarction; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Multivariate Analysis; Nitric Oxide Synthase; Odds Ratio; Risk Factors; Stroke

2006
Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures.
    Neurobiology of disease, 2006, Volume: 22, Issue:1

    Topics: Animals; Anticoagulants; Apoptosis; Arginine; Brain Damage, Chronic; Caspase 3; Caspase Inhibitors; Caspases; Cerebral Cortex; Cerebral Hemorrhage; Corpus Striatum; MAP Kinase Signaling System; Nerve Degeneration; Organ Culture Techniques; Oxidative Stress; Phosphorylation; Pipecolic Acids; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Receptor, PAR-1; src-Family Kinases; Sulfonamides; Thrombin; Time Factors

2006
Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury.
    Experimental neurology, 2007, Volume: 206, Issue:1

    Topics: Animals; Arginine; Brain; Brain Damage, Chronic; Cell Death; Cerebral Hemorrhage; Cycloheximide; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gliosis; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Pipecolic Acids; Platelet Aggregation Inhibitors; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin

2007
Hypertonic resuscitation improves neuronal and behavioral outcomes after traumatic brain injury plus hemorrhage.
    Anesthesiology, 2008, Volume: 108, Issue:5

    Topics: Animals; Arginine; Behavior; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Hypertonic Solutions; Male; Rats; Rats, Sprague-Dawley; Resuscitation; Saline Solution, Hypertonic; Treatment Outcome

2008
Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat.
    Neuroreport, 1993, Volume: 4, Issue:3

    Topics: Animals; Arginine; Autoradiography; Blood Gas Analysis; Blood Pressure; Brain; Brain Chemistry; Cerebral Hemorrhage; Cerebrovascular Circulation; Hypotension; Injections, Intravenous; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar; Vascular Resistance

1993
Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Stroke, 2001, Volume: 32, Issue:11

    Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Fibrin; Incidence; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Pipecolic Acids; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator

2001